NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality - Stupp R; Wong ET; Kanner AA; Steinberg D; Engelhard H; Heidecke V; Kirson ED; Taillibert S; Liebermann F; Dbaly V; Ram Z; Villano JL; et al. (European Journal of Cancer, 2012)
FEMU ID: 21459; EMF-Portal URL: https://www.emf-portal.org/en/article/21459